Neurodegenerative diseases - Characteristics and The role of physical activity
DOI:
https://doi.org/10.12775/QS.2024.17.53487Keywords
Alzheimer's disease, amyotrophic lateral sclerosis, dementia, Parkinson's diseaseAbstract
Introduction
Neurodegenerative diseases, increasingly prevalent due to an aging population, involve the degeneration of nerve cells through processes like necrosis and apoptosis. These conditions, such as Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, and Huntington's, affect the brain, spinal cord, and peripheral nerves, leading to motor, psychological, and memory disorders, and can result in premature death. Research indicates that physical activity from a young age can reduce the risk of developing neurodegenerative diseases, with studies showing that exercise induces beneficial neuroplastic changes in both healthy individuals and patients.
Aim of the study
The aim of the study is to provide a comprehensive analysis of neurodegenerative diseases. Through a detailed discussion of these issues, our goal is to increase public awareness of neurodegenerative diseases and provide readers with comprehensive knowledge about this diseases.
Material and method
This article presents the current state of knowledge about neurodegenerative diseases. A literature review was conducted using the PubMed, Google Scholar and Web of Science databases, utilizing keywords such as " Parkinson's disease", " amyotrophic lateral sclerosis", "Alzhaimer's disease".
References
Gilter A, Dhillon P, Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis Model Mech. 2017;10(5):499-502. doi: 10.1242/dmm.030205
Gaweł M., Potulska-Chromik A. Neurodegenerative diseases: Alzheimer’s and Parkinson’s disease. Advances in Medical Science. 2015;28(7):468-476
Mahalakshmi B. Maurya N, Lee S, Kumar B. Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration. Int J Mol Sci. 2020; 21(16): 5895.
doi: 10.3390/ijms21165895
Szwed A., Miłowska K. The role of proteins in neurodegenerative diseases. Advances in Hygiene of Experimental Medicine. 2012; 66: 187-195. doi: 10.5604/17322693.991446
Van Praag H. Lifestyle Factors and Alzheimer’s Disease. Brain Plasticity.
; 4(1): 1–2. doi: 10.3233/BPL-120418
Holger J. Memory loss in Alzheimer’s disease. Dialogues in Clinical Neuroscience. 2013;15(4): 445-454. doi: 10.31887/DCNS.2013.15.4/hjahn
Knopman D, Amieva H, Peterson R, Chételat G, Holtzman D, Hymen B, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33. doi: 10.1038/s41572-021-00269-y
Scheltens P, Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen C, et al. Alzheimer disease. Lancet. 2021;397(10284):1577-1590.
doi: 10.1016/S0140-6736(20)32205-4
DeMaagd G., Philip A. Parkinson’s Disease and Its Management Part Disease
Entity. Risk Factors, Pathophysiology. Clinical Presentation and Diagnosis.
; 40(8):504-532.
Rizek P., Kumar N., Jong M.S. An update on the diagnosis and treatment of
Parkinson disease. Canadian Medical Association Journal. 2016;188(16): 1157–1165.
Karpińska A, Gromadzka G. Oxidative stress and natural antioxidant mechanisms: the role in neurodegeneration. From molecular mechanisms to therapeutic strategies. Advances in Hygiene of Experimental Medicine. 2013;67: 43-53. doi:10.5604/17322693.1129686
Jankovic J, Tan E. Parkinson’s disease: etiopathogenesis and treatment. Neurol Neurosurg Psychiatry 2020;91:795–808. doi:10.1136/jnnp-2019-322338
Worth PF. When the going gets tough: how to select patients with Parkinson's
disease for advanced therapies. Practical Neurology. 2013;13(3):140-52.
doi: 10.1136/practneurol-2012-000463
Reich S, Savitt J. Parkinson's Disease. Med Clin North Am. 2019;103(2):337-350.
doi: 10.1016/j.mcna.2018.10.014
Armstrong M, Okun M. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323(6):548-560. doi: 10.1001/jama.2019.22360
Halli-Tierney A, Luker J, Carroll D. Parkinson Disease. Am Fam Physician. 2020;102(11):679-691
Wijesekera L, Nigel Leigh P. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4: 3. doi: 10.1186/1750-1172-4-3
Testa D, Lovati R, Ferrarini M, Salmoiraghdi F, Filippini G. Survival of 79
patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotrophic
Lateral Sclerosis and Other Motor Neuron Disorders.2004; 5(4):208-12.
Ghasemi M, Brown R. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb Perspect Med. 2018; 8(5): a024125. doi: 10.1101/cshperspect.a024125
Broom W, Russ C, Sapp P, McKenna-Yasek D,Hosler B, Andersen P, Brown R. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes. Neurosci Lett. 2006;392(1-2):52-7.
doi: 10.1016/j.neulet.2005.08.058
Mitsumoto H, Bromberg M, JohnstonW, Tandan R, Byock I, Lyon M. et al. Promoting excellence in end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(3):145-54. doi: 10.1080/14660820510028647
Brown R, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377(2):162-172. doi: 10.1056/NEJMra1603471
Tsai MJ, Hsu CY, Sheu C. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377(16):1602. doi: 10.1056/NEJMc1710379
Bonanni R, Cariati I, Tarantino U, D’Arcangelo G, Tancredi V. Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases. J Funct Morphol Kinesiol. 2022; 7(2): 38. doi: 10.3390/jfmk7020038
Mahalakshmi B, Maurya N, Lee S, Kumar B. Possible Neuroprotective Mechanisms of Physical Exercise in Neurodegeneration. Int J Mol Sci. 2020; 21(16): 5895.
doi: 10.3390/ijms21165895
Colucci-D'Amato L, Speranza L, Volpicell F. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int J Mol Sci. 2020 Oct 21;21(20):7777. doi: 10.3390/ijms21207777
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Magda Madoń, Julia Sieniawska, Daria Sieniawska, Angelika Kamizela
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 157
Number of citations: 0
